KR20230066356A - 바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도 - Google Patents

바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도 Download PDF

Info

Publication number
KR20230066356A
KR20230066356A KR1020237008289A KR20237008289A KR20230066356A KR 20230066356 A KR20230066356 A KR 20230066356A KR 1020237008289 A KR1020237008289 A KR 1020237008289A KR 20237008289 A KR20237008289 A KR 20237008289A KR 20230066356 A KR20230066356 A KR 20230066356A
Authority
KR
South Korea
Prior art keywords
formulation
fucoidan
combination preparation
chitosan
viral infection
Prior art date
Application number
KR1020237008289A
Other languages
English (en)
Korean (ko)
Inventor
슈리앙 송
아이구어 지
Original Assignee
산동 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산동 유니버시티 filed Critical 산동 유니버시티
Publication of KR20230066356A publication Critical patent/KR20230066356A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020237008289A 2020-08-24 2021-01-13 바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도 KR20230066356A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010857170.7A CN111773182B (zh) 2020-08-24 2020-08-24 一种预防病毒传染的复方制剂及其配制/使用方法与应用
CN202010857170.7 2020-08-24
PCT/CN2021/071507 WO2022041634A1 (zh) 2020-08-24 2021-01-13 一种预防病毒传染的复方制剂及其配制/使用方法与应用

Publications (1)

Publication Number Publication Date
KR20230066356A true KR20230066356A (ko) 2023-05-15

Family

ID=72762525

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237008289A KR20230066356A (ko) 2020-08-24 2021-01-13 바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도

Country Status (3)

Country Link
KR (1) KR20230066356A (zh)
CN (1) CN111773182B (zh)
WO (1) WO2022041634A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111773182B (zh) * 2020-08-24 2022-08-02 山东大学 一种预防病毒传染的复方制剂及其配制/使用方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050004071A1 (en) * 2003-04-21 2005-01-06 Comper Wayne D. Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses
CN104383887B (zh) * 2014-11-12 2017-02-15 青岛海洋生物医药研究院股份有限公司 壳聚糖、壳寡糖及其衍生物在制备吸附大气污染物的吸附剂中的应用
CN104436205B (zh) * 2014-12-12 2018-06-15 中国海洋大学 一种以海洋硫酸多糖制备的纳米载体及纳米复合体与应用
CN106466482A (zh) * 2015-08-20 2017-03-01 康多宝医疗健康产品（湖南）有限公司 一种预防、治疗或抑制粘膜疾病的组合物及其制备方法
FR3056911B1 (fr) * 2016-10-03 2019-07-19 Ys Lab Composition aqueuse derivee d’eau de mer et d’algues marines
CN106581148A (zh) * 2017-02-28 2017-04-26 四川艾医生医疗科技有限公司 一种鼻腔冲洗护理液
CN107375217A (zh) * 2017-06-26 2017-11-24 华侨大学 一种碳酸钙‑(聚鸟氨酸/岩藻聚糖)4自组装载体及制备方法
CN108619095B (zh) * 2018-05-29 2020-12-18 宁波科瑞特动物药业有限公司 一种壳聚糖医用杀菌喷雾
CN108721610A (zh) * 2018-06-25 2018-11-02 济南瑞丰生物工程有限公司 一种含壳聚糖的鼻腔润湿剂及其制备方法
CN109010125A (zh) * 2018-09-30 2018-12-18 青岛弘海生物技术有限公司 一种具有抑菌功能的防霾喷雾剂
CN111529685A (zh) * 2020-04-21 2020-08-14 厦门诺康得生物科技有限公司 抗呼吸道病毒感染的鼻腔喷雾制剂
CN111773182B (zh) * 2020-08-24 2022-08-02 山东大学 一种预防病毒传染的复方制剂及其配制/使用方法与应用

Also Published As

Publication number Publication date
CN111773182B (zh) 2022-08-02
WO2022041634A1 (zh) 2022-03-03
CN111773182A (zh) 2020-10-16

Similar Documents

Publication Publication Date Title
ES2949139T3 (es) Composición que elimina la congestión nasal y que tiene actividad antivírica
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
KR20150102995A (ko) 경비 인플루엔자 백신 조성물
CN106668832B (zh) 一种多肽在制备治疗肠道病毒感染药物的应用
CN100444734C (zh) 一种复方抗病毒喷雾剂及其制备方法
US8802641B2 (en) Method for inhibiting onset of or treating pollen allergy
US20130171262A1 (en) Honey based compositions of a consistency that can be delivered to the respiratory system
KR20230066356A (ko) 바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도
Ait Hamdan et al. The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic
MX2008009117A (es) Uso del extracto de la baya del sauco.
CN104546715B (zh) 一种用于上呼吸道感染的复合抗体口腔喷剂及其制备方法
WO2015082965A2 (en) Novel chitosan nasal wash
CN111388421A (zh) 一种具有抗菌和抗病毒功能的口鼻喉双组分喷剂及制备方法
CN105381454A (zh) 一种含海藻糖的鼻腔润湿剂
RU2311194C1 (ru) Гомеопатическое средство "анавиарин-гомеоантигриппин", обладающее противовирусным действием (варианты)
JP2001527166A (ja) ウイルス捕捉用材料
RU2702124C2 (ru) Способ профилактики и терапии отодектоза плотоядных животных и псороптоза кроликов
RU2192877C1 (ru) Лечебно-профилактическая композиция ингредиентов для бальзама
US20050196472A1 (en) Methods of treating against viral infection using berries juice fractions
CN113350487A (zh) 一种抗病毒组合物及其制备方法和应用
RU2702123C2 (ru) Способ профилактики и терапии отодектоза плотоядных животных и псороптоза кроликов
CN111803650B (zh) 酪胺-岩藻聚糖在预防病毒经黏膜传播中的应用及其制备方法、药剂
CN101084892A (zh) 一种抗呼吸道病毒的药物及用途
RU2297246C1 (ru) Способ снижения токсичности амфотерицина в
RU2418605C1 (ru) Способ лечения респираторных болезней телят